The Israeli Health Basket Committee for 2026 has concluded its work and submitted a list of new medicines and technologies to Health Minister Chaim Katz, entailing a budget of 650 million shekels. Notably, over 50% of the funding is dedicated to oncology, reflecting the increasing need and prioritization of cancer treatment in the healthcare system. Additionally, the committee has included more medications aimed at addressing mental health issues, indicating a growing recognition of the importance of mental wellness in public health policy.

The submission of the committee's decisions has been notably delayed by nearly three months due to a coalition crisis that resulted in the resignation of Former Health Minister Urielu Bosso. Following his departure in July, there was a significant postponement in the appointment of the committee. Uniquely, members of the Health Basket Committee were appointed by the Prime Minister and the Minister of Finance, rather than the Health Minister, which is customary and has raised concerns about the implications for the healthcare decision-making process in Israel.

This shift in committee appointment and the focus on oncology and mental health treatments signal a crucial evolution in Israel's healthcare priorities. The allocation of funds and resources not only responds to pressing health needs but also invites scrutiny regarding how political dynamics affect health policy making. As health initiatives increasingly intertwine with political landscapes, the outcomes of such decisions can have far-reaching implications on public health and welfare in Israel.